Profile data is unavailable for this security.
About the company
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
- Revenue in USD (TTM)13.55m
- Net income in USD-3.69m
- Incorporated2006
- Employees172.00
- LocationSonoma Pharmaceuticals Inc5445 CONESTOGA COURT, SUITE 150BOULDER 80301United StatesUSA
- Phone+1 (617) 243-0050
- Fax+1 (707) 283-0551
- Websitehttps://sonomapharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scorpius Holdings Inc | 10.04m | -29.66m | 2.86m | 82.00 | -- | 0.0813 | -- | 0.2846 | -107.62 | -101.17 | 5.25 | 8.12 | 0.1725 | -- | 16.55 | 122,491.30 | -53.23 | -39.37 | -69.92 | -43.18 | 61.92 | -- | -308.58 | -1,068.21 | 0.6007 | -27.31 | 0.3146 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.53m | 2.87m | 13.00 | -- | 0.7727 | -- | -- | -4.86 | -4.86 | 0.00 | 1.14 | 0.00 | -- | -- | 0.00 | -176.99 | -84.35 | -209.96 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0022 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 2.98m | -- | -- | -- | 1.97 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Scisparc Ltd | 0.00 | -6.96m | 2.99m | 3.00 | -- | 8.40 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| China Pharma Holdings Inc | 5.54m | -4.74m | 3.42m | 231.00 | -- | 0.5444 | -- | 0.616 | -0.3958 | -0.3958 | 0.4119 | 0.3655 | 0.3848 | 2.38 | 15.81 | 24,002.68 | -32.92 | -29.66 | -55.81 | -55.25 | -34.34 | 6.47 | -85.56 | -73.09 | 0.2605 | -27.44 | 0.377 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| NovaBay Pharmaceuticals Inc | 11.20m | -16.44m | 3.52m | 24.00 | -- | 3.30 | -- | 0.314 | -53.22 | -53.40 | 7.77 | 0.2195 | 1.34 | 2.22 | 13.83 | 466,625.00 | -119.49 | -61.51 | -196.48 | -83.89 | 60.67 | 59.99 | -89.25 | -86.47 | 0.9103 | -- | 0.0454 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 3.59m | 4.00 | -- | 0.8998 | -- | 898.23 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonoma Pharmaceuticals Inc | 13.55m | -3.69m | 3.90m | 172.00 | -- | 0.7278 | -- | 0.2877 | -4.91 | -4.91 | 16.95 | 4.00 | 0.9917 | 3.11 | 5.04 | 78,761.63 | -26.98 | -29.36 | -35.49 | -40.65 | 38.52 | 38.00 | -27.21 | -30.93 | 2.84 | -- | 0.0151 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Silo Pharma Inc | 72.12k | -3.71m | 4.08m | 3.00 | -- | 0.6017 | -- | 56.58 | -1.16 | -1.19 | 0.022 | 1.51 | 0.0082 | -- | -- | 24,040.00 | -42.31 | -24.90 | -46.92 | -26.39 | 91.90 | 82.79 | -5,149.53 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 4.16m | -- | 0.0232 | 0.005 | 1.14 | 0.3906 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Biofrontera Inc | 35.36m | -12.84m | 4.21m | 85.00 | -- | 0.8962 | -- | 0.119 | -1.63 | -1.63 | 8.82 | 0.8469 | 1.34 | 1.66 | 6.21 | 415,988.30 | -48.79 | -- | -205.99 | -- | 47.11 | -- | -36.30 | -- | 0.9432 | -6.43 | 0.00 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Sunshine Biopharma Inc | 32.96m | -4.23m | 4.24m | 44.00 | -- | 0.1694 | -- | 0.1286 | -144.23 | -144.23 | 95.92 | 12.52 | 1.14 | 3.18 | 12.55 | 749,079.60 | -14.65 | -101.52 | -17.57 | -137.04 | 30.78 | 35.47 | -12.82 | -165.33 | 3.57 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| AgriFORCE Growing Systems Ltd | 57.60k | -15.05m | 4.76m | 7.00 | -- | 0.3024 | -- | 82.71 | -5.81 | -5.81 | 0.0037 | 0.1343 | 0.0034 | -- | 1.21 | 8,228.57 | -88.79 | -78.95 | -124.14 | -109.86 | 17.86 | -- | -26,121.49 | -243,182.50 | 1.24 | -1.28 | 0.0789 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| Aoxing Pharmaceutical Company Inc | 30.11m | -1.46m | 4.95m | 339.00 | -- | 0.0578 | -- | 0.1643 | -0.0192 | -0.0192 | 0.3951 | 0.2507 | 0.496 | 2.32 | 2.56 | -- | -2.41 | -14.54 | -7.06 | -35.45 | 76.19 | 68.51 | -4.85 | -37.69 | 0.7368 | 0.3387 | 0.6052 | -- | 26.88 | 37.20 | -62.49 | -- | -38.80 | -- |
Data as of Nov 22 2024. Currency figures normalised to Sonoma Pharmaceuticals Inc's reporting currency: US Dollar USD
2.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Securities LLCas of 30 Sep 2024 | 12.73k | 0.95% |
| Ground Swell Capital LLCas of 30 Sep 2024 | 10.40k | 0.78% |
| Tower Research Capital LLCas of 30 Sep 2024 | 4.14k | 0.31% |
| Citigroup Global Markets, Inc. (Investment Management)as of 30 Sep 2024 | 180.00 | 0.01% |
| JPMorgan Securities LLC (Investment Management)as of 30 Sep 2024 | 138.00 | 0.01% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 113.00 | 0.01% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2024 | 27.00 | 0.00% |
| RBC Capital Markets LLC (Investment Management)as of 30 Sep 2024 | 26.00 | 0.00% |
| U.S. Bank NA (Cincinnati Ohio Investment Management)as of 30 Sep 2024 | 25.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 4.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
